VVeno Medical (Nasdaq:NVNO) announced three-year outcomes for its heart valve that it aims to submit to the FDA this year.

To see if these at-home vagal nerve stimulators might actually do anything, I tested the Truvaga Plus VNS device everyday for ...

Patients awaiting a heart transplant are often implanted with an ... and funding for pediatric heart devices. The network is working with the U.S. Food and Drug Administration (FDA) to expand ...

Vagus nerve stimulation devices may help improve workouts, sleep, and mood. Writer Tianna Soto tried the Truvaga Plus for two ...

According to the NIH, about 1.6 million people in the U.S. suffer from a condition where the tricuspid valve does not properly close ...

Abbott Laboratories has announced that its implantable heart device, MitraClip, has not been recommended for approval by reviewers at the US Food and Drug Administration. Clinical trials ...

Medtronic plc, a global leader in healthcare technology, received US Food and Drug Administration ... electrical conduit between the device and the heart. The lead senses the heartbeat, and transmits ...

The FDA approved the treatment in 2024, and Medicare & Medicaid approved reimbursement earlier this year. Sarasota Memorial Hospital’s heart team ... the new valve, implanted by Yaryura.

[Image from Abbott/FDA] The FDA ... assist device (LVAD) systems. These systems feature an implantable pump diverting blood from the weakened left ventricle of the heart, pumping it to the aorta.

Carmat is preparing to commence implants ... tumour. "FDA conditionally approves second cohort of Carmat’s artificial heart study" was originally created and published by Medical Device Network ...

Cancer is cruel. It doesn’t care that you’re only 37, that you're the mother of a little girl who is your entire world. So Elissa vowed to fight.